Brief: SOBI 2025 Outlook Unchanged
April 29 (Reuters) - Swedish Orphan Biovitrum AB (publ) SOBIV.ST: Q1 REVENUE SEK 6,465 MILLION VERSUS. IBES ESTIMATE SEK 6,267 MILLION Q1 EBIT SEK 1,358 MILLION Q1 ADJUSTED FREE CASH FLOW SEK 2,295 MILLION Q1 ADJUSTED EPS SEK 2.55 2025 OUTLOOK UNCHANGED ON TARIFFS: TARIFFS ARE PARTLY PAUSED, POTENTIAL FUTURE IMPACT CANNOT BE ESTIMATED AT THIS POINT Source text: ID:nWkr63gPCQ Further company coverage: SOBIV.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Swedish Orphan Biovitrum AB (publ)
See all newsTop of the Street: SOBI, Sonova, BAT, Imperial Brands
SOBI slips after Ionis lowers Tryngolza sales forecast
Brief: Swedish Orphan Biovitrum Executive Sells, Buys Shares
Europe Research Roundup: Centrica, Fuchs, URW
Brief: Swedish Orphan Biovitrum Proposes Börje Ekholm As New Chair And Board Member At 2027 AGM